Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LTRN
LTRN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LTRN News
Lantern Pharma Launches AI Drug Discovery Platform with Subscription Tiers
6d ago
Newsfilter
Lantern Pharma Unveils AI Drug Development Platform with Zeta.ai
Apr 02 2026
Newsfilter
Lantern Pharma Q4 2025 Earnings Call Insights
Mar 31 2026
seekingalpha
Lantern Pharma Reports Reduced Q4 Net Loss
Mar 30 2026
seekingalpha
PMGC Holdings Unit Amends Clinical Trial Agreement
Mar 30 2026
stocktwits
Leading Pre-Market Gainers Today — ELAB, ITRM, LTRN Among Stocks Rising Ahead of Market Open
Mar 30 2026
stocktwits
Lantern Pharma Receives FDA IND Approval for STAR-001
Mar 30 2026
NASDAQ.COM
Lantern Pharma CEO Panna Sharma Remains in Position, Addresses False Claims
Mar 27 2026
Newsfilter
LANTERN PHARMA AFFIRMS PANNA SHARMA REMAINS PRESIDENT AND CEO; WARNS INVESTORS ABOUT INACCURATE THIRD-PARTY REPORT
Mar 27 2026
moomoo
Lantern Pharma Receives FDA Clearance for STAR-001 Pediatric Trial
Mar 27 2026
NASDAQ.COM
LANTERN PHARMA STOCK RISES 7.1% FOLLOWING FDA APPROVAL FOR CHILD BRAIN CANCER TREATMENT TRIAL
Mar 27 2026
moomoo
Lantern Pharma Receives FDA IND Approval for STAR-001
Mar 27 2026
stocktwits
FDA Approves STAR-001 for Pediatric CNS Cancer Trial
Mar 27 2026
Newsfilter
RedChip Releases AI Investor Conference Replays
Mar 27 2026
Yahoo Finance
Lantern Pharma to Host Q4 2025 Earnings Webcast on March 30
Mar 23 2026
Newsfilter
Growth Prospects for the EGFR-NSCLC Market Analyzed
Feb 11 2026
Newsfilter
Show More News
